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1. Introduction 
Bicuspid aortic valve (BAV) is the most common congenital abnormality of the human heart, 
affecting approximately 1-2% of the general population (Williams, 2006). It is widely 
accepted that BAV is a very heterogeneous disease and that the different phenotypes of BAV 
disease may be caused by unique pathogenetic mechanisms. Because the heterogeneous 
nature of BAV disease has been recognized by many researchers, attempts have been made 
to stratify the most common anatomic-clinical forms. 
The clinically observed linkage between specific BAV morphology and the associated 
lesions of the proximal aorta has recently led to several phenotypic classifications which 
incorporate both valve and proximal aortic anatomy. These different BAV phenotypes may 
be caused by unique pathogenetic mechanisms and may require different therapeutic 
approaches. The clarification of this phenomenon will undoubtedly affect the individual 
treatment strategy of BAV disease. 
In the face of these novel findings, this chapter deals with recent controversies in BAV 
disease. 
2. Phenotypes in BAV disease 
The recently identified BAV phenotypes incorporate specific aortic valve anatomy (or a 
predominant type of aortic valve dysfunction) and concomitant lesions of the proximal 
aorta. To begin with, these empirical observations were based on the surgical and 
echocardiographic findings of an association between specific BAV disease and concomitant 
lesions of aortic root, ascending aorta, or both. Configuration of the proximal aorta is 
undoubtedly different in patients with BAV stenosis versus BAV insufficiency. Moreover, 
there are apparently distinct forms of proximal aortic lesions in patients with fusion of right 
coronary and left coronary cusps versus fusion of right coronary and non-coronary cusps in 
BAV disease. 
These specific associations of BAV anatomy and proximal aortic disease have been analyzed 
by a large number of in vitro, rheological and biomolecular investigations. These novel BAV 
phenotypes and the corresponding fundamental research articles will be addressed in detail 
in the following paragraphs. 
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2.1 BAV stenosis versus BAV insufficiency 
The strong correlation between specific aortic dilatation patterns and the functional status of 
BAV (i.e., BAV stenosis versus insufficiency) has been demonstrated by some investigators 
based on the empirical analysis of clinical data. In particular, the presence of BAV stenosis is 
typically associated with asymmetrical dilatation of the mid-ascending aorta and a nearly 
normal aortic root diameter (Cotrufo & Della Corte, 2009). In contrast, aortic root dilatation 
is more often associated with a concomitant or consequent BAV insufficiency (i.e., root 
dilatation phenotype). 
Different pathogenetic mechanisms have been proposed for those two apparently different 
BAV phenotypes (Cotrufo & Della Corte, 2009). Importantly, significant differences in the 
expression and spatial distribution of extracellular matrix (ECM) proteins have been found 
between these two subgroups of BAV disease (i.e., aortic valve stenosis versus insufficiency). 
Both BAV phenotypes have been linked to the specific patient’s characteristics and will be 
discussed in detail. 
2.1.1 BAV stenosis with an asymmetric mid-ascending aortic dilatation 
This most common anatomical-clinical BAV phenotype includes stenosis of the BAV, an 
unaffected or only mildly dilated aortic root, and an asymmetric dilation of the mid-
ascending aorta, starting from the sinotubular junction and involving mostly the convexity 
(i.e., the greater curvature) of the vessel (Fig. 1). The association between BAV stenosis and 
asymmetric mid-ascending aortic dilatation has been proposed to be pathogenetic (Della 
Corte et al., 2007). 
 
 
 
Fig. 1. Magnetic resonance imaging demonstrating an asymmetric mid-ascending aortic 
aneurysm in a patient with BAV stenosis 
It has been proved that stenosis of the BAV, which is geometrically asymmetrical, produces 
an eccentric turbulent transvalvular blood flow that results in asymmetrical wall stress 
distribution in the ascending aorta (Fig. 2) (Robicsek et al., 2004). It has been hypothesized 
that this uneven wall stress distribution may be important in promoting early localized 
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aortic wall changes, which may lead subsequently to an asymmetric ascending aortic 
dilatation. These flow-dependant changes in the microstructure of the vessel wall are known 
as a flow-induced vascular remodeling (Lehoux et al., 2002). 
 
 
Fig. 2. Stress patterns in the proximal aorta in the setting of an eccentric BAV. The red and 
yellowish brown segments of the proximal aorta are the most stressed by the eccentric 
transvalvular blood flow; the blue segments are the least stressed (published in Annals of 
Thoracic Surgery 2004; 77:177-185) 
According to these data, this pathogenetically linked anatomical-clinical BAV phenotype 
(i.e., BAV stenosis with an asymmetric mid-ascending aortic dilatation) may represent the 
predominantly hemodynamically triggered form of BAV aortopathy. In compliance with 
these findings, some most recent in vitro and in vivo studies provide further evidence of the 
hemodynamic nature of this BAV phenotype. 
2.1.1.1 Correlation between BAV stenosis and the extent of mid-ascending aortic 
dilatation 
Given the marked heterogeneity of BAV disease and the co-existence of different clinical-
anatomical phenotypes, the data on the correlation between the type of BAV dysfunction 
and the extent of proximal aortic dilation are very controversial. However, when the 
analysis has been focused on the mid-ascending aortic dilatation form alone, a strong 
correlation has been found between the degree of BAV stenosis and the extent of ascending 
aortic dilatation at maximum diameter (Della Corte et al., 2007). 
Similar findings have been recently reported by some other investigators (Davies et al., 
2007). These authors were able to clearly demonstrate a strong association between the 
presence of aortic valve stenosis and all adverse aortic events in the BAV subgroup. 
Moreover, a significant correlation has been demonstrated most recently between the degree 
of eccentricity of the systolic transvalvular flow through the BAV and the severity of the 
proximal aortic dilatation in the pediatric BAV subpopulation (i.e., the larger the angle of 
misdirected blood flow with the aortic axis, the larger the proximal aortic diameter) (den 
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Reijer et al., 2010). These correlations were most significant at the more distal level of the 
ascending aorta, where aortic wall stress is expectedly highest. 
These results favour the hemodynamic hypothesis of BAV-associated aortopathy (i.e. 
abnormal blood flow patterns induced by BAV stenosis are directly involved in the 
development of ascending aortic dilatation). 
2.1.1.2 Functioning of the “clinically normal” BAV 
There is emerging evidence that the “clinically normal” BAV (i.e., one without a 
quantitatively detectable transvalvular pressure gradient by continuous-wave Doppler 
methods of grading) is morphologically stenotic and is associated with an abnormal 
eccentric systolic transvalvular flow, which results in asymmetrical wall stress distribution 
in the ascending aorta (Robicsek et al., 2004). 
This has been recently demonstrated in a sophisticated mathematical analysis, using a 
dynamic three-dimensional (3D) finite element model of the bicuspid aortic root (Conti et al., 
2010). These investigators were able to convincingly demonstrate that the mere fusion of the 
two aortic valve cusps restricts the opening motion of the conjoined cusp, which causes 
subclinical BAV stenosis. Moreover, the longitudinal stress at the convexity of the ascending 
aorta has been found to be increased by 36% in BAV versus the tricuspid aortic valve (TAV) 
aortic root finite element model. 
The in vitro data have been supported most recently by an in vivo analysis of systolic 
transvalvular flow in BAV patients using sophisticated four-dimensional magnetic 
resonance imaging (MRI) (Hope et al., 2010). The authors of this study demonstrated 
convincingly a nested helical systolic flow pattern in the proximal aorta in patients with 
BAV, including those without ascending aortic dilatation or significant BAV stenosis (Fig. 3). 
These abnormal systolic transvalvular flow patterns were shown to be different and unique 
for the two most common cusp fusion types in patients with BAV. 
 
     
                                                   (a)                                                   (b) 
Fig. 3. Systolic transvalvular flow patterns in the proximal aorta in a patient with TAV (a) 
and BAV (b) (published in Radiology 2010; 77:177-185) 
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All above-mentioned studies clearly indicate that the eccentric opening of “clinically 
normal” BAV is enough to generate significant flow disturbances downstream (e.g., 
turbulence, vortices, nested helical flow patterns, asymmetrically arranged flow), which 
may induce permanent mechanical stimuli to the ascending aortic wall, and, subsequently, 
asymmetric aortic dilation. 
2.1.1.3 Asymmetric pattern of aortopathy in BAV disease 
The concept of asymmetry in ascending aortic disease was first introduced by Cotrufo et al. 
(2001). This was based on the empirical macroscopic surgical observations of asymmetric 
ascending aortic aneurysms propagating from the right anterolateral aortic wall (i.e., 
convexity or a greater curvature). 
The enlargement of the tubular mid-ascending aorta in patients with BAV disease has a 
typical asymmetric configuration at the convexity of the vessel, as shown in the 
retrospective analysis of aortic angiograms (Bauer et al., 2006). Moreover, the distance 
between the aortic valve level and the level of the maximal ascending aortic diameter was 
found to be greater in BAV patients versus TAV patients. 
The asymmetric pattern of the ascending aortic wall alterations has been confirmed by a 
series of consecutive histological and biomolecular investigations by Cotrufo et al. (2005). 
Consecutive studies have shown an asymmetric spatial pattern of extracellular matrix 
(ECM) protein expression and smooth muscle cell (SMC) changes in the convexity versus 
the concavity of the dilated ascending aorta in BAV patients (Cotrufo et al., 2005; Della Corte 
et al., 2006, 2008). Moreover, this asymmetric pattern of microstructural aortic wall changes 
has been found in non-dilated aortas in the setting of BAV stenosis. 
This proven asymmetry of BAV aortopathy, which may be interpreted as a result of aortic 
wall stress-induced vascular remodeling, lends more credence to the hemodynamic nature 
of BAV stenosis-associated aortopathy. 
In conclusion, the identified predominant anatomical-clinical BAV phenotype of BAV 
stenosis with an asymmetric mid-ascending aortic dilatation may include those patients in 
whom the hemodynamic factors play a determinant role. 
 
2.1.2 BAV insufficiency with a dilatation of aortic root (root dilatation phenotype) 
There is a relatively small subset of BAV patients (10-15%), who present with the 
predominant aortic root dilatation at the level of aortic annulus and the sinuses of Valsalva. 
This form of proximal aortic dilatation is commonly associated with a varying degree of 
concomitant or consequent aortic valve insufficiency. This relatively rare clinical-anatomical 
form of BAV disease has been described in the literature as a “root dilatation phenotype” 
(Della Corte et al., 2007) (Fig. 4). 
The prevalence of the root phenotype does not increase with age (it occurs primarily in the 
young BAV population) and shows a strong predilection for the male gender. It has been 
hypothesized, that this phenotype may be subtended by a less flow-dependent mechanism 
of aortic wall failure than is asymmetric mid-ascending aortic dilatation, and that it may 
coexist with every possible degree of aortic valve dysfunction. It has also been proposed that 
the root dilatation phenotype may be a purely genetic form of BAV disease and a 
completely different disease from BAV stenosis and asymmetric mid-ascending aortic 
dilatation (Cotrufo & Della Corte, 2009). 
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A subgroup of young male BAV patients with the predominant aortic dilatation at the level 
of the aortic root that occurred independently of age, body size, and aortic valve function 
has been also prospectively identified in a echocardiographic study (Nistri et al., 1999). The 
authors of this report hypothesized that there may be a subgroup of BAV patients who are 
affected by the congenital weakness of the aortic wall structure that causes premature aortic 
root dilatation, independent of any hemodynamic perturbations. 
 
   
                                       (a)                                                                          (b) 
Fig. 4. Images of aortic angiography (a) and transthoracic echocardiography (b) in BAV 
patient with a “root phenotype” 
Although the genetic nature of the root dilatation phenotype has been postulated by all the 
above-mentioned studies, no specific gene defect responsible for this type of BAV disease 
has been ever identified. Moreover, there is a notable paucity of clinical and biomolecular 
data on the BAV subgroup with a “root phenotype”. 
Nonetheless, some important indices of the genetic origin of this clinical-anatomical form of 
BAV disease may be identified in the recent literature and will be discussed in detail as 
follows. 
2.1.2.1 Evidence of the genetic nature of the root dilatation phenotype 
A recent study by Loscalzo et al. (2007) analyzed a small number of selected families with  
a high prevalence of BAV disease and familial thoracic aortic aneurysms (TAA). Based on 
the genetic analysis of thirteen affected families, the authors concluded that BAV and 
familial thoracic aortic aneurysms are variably penetrant independent manifestations of a 
single gene defect which may be associated with a wide spectrum of left outflow tract 
disorders. 
However, only fifteen family members of the analyzed probands (13%) had BAV in this 
study and only ten of them (9%) had a concomitant thoracic aortic aneurysm (i.e., the study 
included only a small subgroup of patients with a combined BAV/TAA phenotype). 
Moreover, three patients in the BAV/TAA subgroup had a significant aortic valve 
dysfunction (i.e., moderate or greater valve insufficiency or stenosis). Therefore, conclusions 
should be only cautiously drawn from such a limited number of affected patients. 
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The recently published echocardiographic study by Biner et al. (2009) focused on aortopathy 
in first-degree relatives of BAV patients. Unfortunately, this study included only a small 
proportion of first-degree relatives of BAV patients (i.e., 48 relatives of 54 BAV patients) and 
compared them with a highly selective control group (i.e., 45 healthy individuals without 
structural heart disease, who were included during a study period of 4 years). Irrespective 
of those methodological flaws, this study has demonstrated a high prevalence of mild aortic 
root dilatation, which was associated with abnormal elastic properties of proximal aorta in 
the first-degree relatives of BAV patients. Notably, this series included predominantly BAV 
patients with aortic dilatation at the level of aortic annulus and sinuses of Valsalva (i.e., the 
root dilatation phenotype of BAV disease). 
We reported most recently on a patient with familial BAV disease and the root dilatation 
phenotype, who was operated on for proximal aortic aneurysm (Girdauskas et al., 2011a). 
The surgery was complicated by intraoperative aortic dissection. Multi-generational genetic 
analysis was performed thereafter and revealed a mutation in the transforming growth 
factor-beta receptor type II (TGFBR2) gene in our patient and her father. 
Some specific features were indicative of a genetic origin of the BAV-associated aortopathy 
in this patient. The strong family history of BAV disease associated with the root dilatation 
phenotype, the marked fragility of the aortic wall (which led to the intraoperative aortic 
dissection), and the histological pattern of symmetric medial degeneration (i.e., cystic 
medial necrosis) were indices of a Marfan-syndrome-like connective tissue disorder. 
BAV has been previously described to be an associated feature of an uncommon connective 
tissue disorder known as Loeys-Dietz syndrome, which is characterized by progressive aortic 
dilatation and the triad of hypertelorism, cleft palate or bifid uvula, and craniosynostosis. 
However, no predictive clinical signs of this syndrome were found in the affected family in 
our case. 
Mutations in the TGFBR1 and TGFBR2 genes have been recently demonstrated to result in a 
wide spectrum of Marfan syndrome-related genetic disorders (e.g., Loeys-Dietz syndrome, 
and familial thoracic aortic aneurysms and dissections). However, thus far, mutations in the 
TGFBR1 and TGFBR2 genes have not been found in patients with BAV disease (Arrington et 
al., 2008; Loscalzo et al., 2007). The possible explanation for this finding may be the 
heterogeneous nature of BAV disease (i.e., genetic analysis in these studies was not focused 
on BAV patients with the root dilatation phenotype). 
Because there are no targeted genetic studies or detailed surgical reports that have focused 
on the root dilatation phenotype of BAV disease, the true incidence of TGFBR mutations in 
BAV disease is not known. 
In conclusion, the above discussed data suggest that the proximal aortic dilatation associated 
with BAV stenosis versus that associated with BAV insufficiency should be considered as 
different diseases that are possibly amenable to different therapeutic approaches. The 
heterogeneous nature of BAV disease and the above-discussed pathogenetic insights should 
be considered when advocating novel surgical treatment guidelines for BAV-associated 
aortopathy (Guntheroth, 2008). 
The widespread belief that BAV disease is a congenital disorder of vascular connective 
tissue has led to more aggressive treatment recommendations of the proximal aorta in BAV 
patients, approaching the aortic management recommendations for patients with Marfan 
syndrome. However, given the heterogeneity of the complex and multifaceted BAV disease, 
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there is an urgent need for diagnostic tools to reliably distinguish the more from the less 
“malignant” phenotypes of BAV disease (Girdauskas et al., 2011b). 
In the view of above-presented data, it would seem unjustified to extend the surgical 
procedure to the sinuses of Valsalva in BAV patients with aortic valve stenosis and 
asymmetric mid-ascending aortic dilatation. In contrast, the relatively small proportion of 
young male BAV patients with the root dilatation phenotype may benefit from the more 
radical and aggressive surgical treatment strategy. 
2.2 Different cusps fusion patterns in BAV disease 
There are two most common patterns of cusp fusion in BAV disease (Fig. 5): the most 
commonly seen fusion of the left and right coronary cusps, occurs in 70-85% of cases, and 
union of the right and non-coronary cusps, occurs in the remaining 15-30% of BAV cases. A 
more detailed classification system of all BAV morphologic variants has been presented by 
Sievers & Schmidtke (2007). 
 
P
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                             270 (86%)                       37(12%) 
Fig. 5. Schema of morphologic BAV classification (published in Mayo Clinic Proceedings 1999; 
74:14-26) 
There is emerging evidence from the recent literature that the different cusp fusion patterns 
in BAV disease are associated with specific lesions of the proximal aorta. The histopathological 
grading of the of aortic wall changes in patients who underwent surgery for BAV disease 
demonstrated a more severe degree of wall degeneration in the ascending aorta in patients 
with fusion of the left coronary and right coronary cusps versus fusion of the right coronary 
and non-coronary cusps (Russo et al., 2007). The prevalence of fibrosis, cystic medial 
necrosis, elastic fragmentation, and inflammation has been shown to be significantly higher 
in patients with fusion of the left coronary and right coronary cusps. 
Moreover, BAV patients with fusion of the left coronary and right coronary cusps were 
significantly younger at the time of surgery and had a significantly larger aortic root 
diameter versus BAV patients with fusion of the right coronary and non-coronary cusps. 
The investigators of this study concluded that the presence of more severe histopathological 
changes at a younger age, and a significantly larger aortic root diameter in BAV patients 
with fusion of the left coronary and right coronary cusps, may be predictive of a more 
accelerated and “malignant” BAV phenotype (Russo et al., 2007). 
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A comparative echocardiographic evaluation of BAV patients with different aortic valve 
cusp fusion patterns brought comparable findings: fusion of the left coronary and right 
coronary cusps was associated with a larger aortic root diameter and a smaller aortic arch, 
than was fusion of the right coronary and non-coronary cusps (Schaefer et al., 2007). 
Moreover, fusion of the left coronary and right coronary cusps correlated with a higher 
aortic stiffness index and lower distensibility at the level of the aortic root. 
The authors hypothesized that the differences in the spatial propagation of blood flow 
through the BAVs with fusion of the left coronary and right coronary cusps versus fusion of 
the right coronary and non-coronary cusps may lead to an inhomogeneous distribution of 
shear stress and, consequently, to differential alterations of the proximal aortic wall. 
The same authors advocated, in their subsequent retrospective analysis (Schaefer et al., 
2008), an integrated phenotypic classification of BAV disease that includes both the cusp 
fusion pattern and the proximal aortic shape. Three different proximal aortic shapes in BAV 
disease were identified (Fig. 6). 
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Fig. 6. Proximal aortic shapes in BAV disease (published in Heart 2008; 94:1634-1638) 
Schaefer et al. arrived at very similar findings: fusion of the left coronary and right coronary 
cusps was associated with normal aortic shape (Type N) but a larger diameter of the aortic 
annulus and sinuses of Valsalva. In contrast, fusion of the right coronary and non-coronary 
cusps resulted in ascending aortic dilatation (Type A) and larger aortic arch dimensions. 
This phenotypic classification has been proposed as a clinical and a research tool in order to 
precisely define BAV subgroups based on the combination of cusp morphology and 
proximal aortic shape. 
Another retrospective echocardiographic study demonstrated, analogously with Schaefer et 
al. (2007, 2008), that fusion of the right coronary and non-coronary cusps correlated with the 
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more rapid growth of ascending aortic diameter in the pediatric population (Holmes et al., 
2007). 
The pathogenetic background for clinical observation of the specific aortic shapes in BAV 
patients with different morphologic cusp fusion patterns has been elucidated in detailed in 
vivo rheological studies using sophisticated 4D magnetic resonance imaging (Hope et al., 
2010). Hope et al. analyzed most recently the transvalvular systolic flow patterns in BAVs 
and demonstrated a markedly abnormal helical flow in patients with BAV, including those 
without ascending aortic dilatation or aortic valve stenosis. This suggests that the abnormal 
systolic flow pattern is not secondary to a dilated aorta or to aortic valve stenosis, but that it 
may be implicated in the pathogenesis of BAV-associated aortopathy. 
Interestingly, Hope et al., (2010) were able to convincingly demonstrate in their study two 
different nested helical flow patterns that are unique for the two most common cusp fusion 
types in patients with BAV (i.e., fusion of the left coronary and right coronary cusps versus 
fusion of the right coronary and non-coronary cusps). 
The most common fusion pattern of the left coronary and right coronary cusps was 
associated with a right-anteriorly directed eccentric systolic flow jet, with a resulting marked 
peripheral skewing towards the convexity of the proximal aorta (Fig. 7a). A left-handed 
nested systolic helical flow, which was observed specifically in patients with fusion of the 
right coronary and non-coronary cusps, was associated with a left-posteriorly directed 
eccentric flow jet (Fig. 7b). 
 
   
                                         (a)                                                                    (b) 
Fig. 7. Different eccentric transvalvular flow patterns in the proximal aorta in a patient with 
BAV and fusion of the left coronary and right coronary cusps (a) and in a patient with BAV 
and fusion of the right coronary and non-coronary cusps (b) (published in Radiology 2010; 
77:177-185) 
Most importantly, Hope et al. (2010) convincingly showed that different morphologic 
patterns of aortic valve cusp fusion in patients with BAV result in the specific orientation of 
systolic flow jets in the proximal aorta. As a logical consequence of this, it may be assumed 
that the direction of eccentric systolic flow would be crucial in determining the specific 
pattern of segmental aortic aneurysm formation in patients with a BAV. Specifically, fusion 
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of the left coronary and right coronary cusps, which generates a right-anterior eccentric flow 
jet, may be linked to asymmetric dilatation of the mid-ascending tubular aorta. Fusion of the 
right coronary and non-coronary cusps, which produces a left-posteriorly directed eccentric 
flow jet, might explain the increased aortic arch dimensions in this subgroup of BAV 
patients. 
Nonetheless, the above-mentioned rheological studies are not able to sufficiently answer all 
relevant questions concerning the pathogenesis of BAV aortopathy. The paucity of data on 
the “root dilatation phenotype” precludes any reasonable explanation for the larger aortic 
root dimensions in BAV patients with fusion of the left coronary and right coronary cusps. 
Asymmetric involvement of the aortic root (i.e., sinuses of Valsalva) in BAV patients has not 
been systematically addressed and, accordingly, there are no specific data on aortic root 
morphology in BAV patients with the “root dilatation phenotype”. Additional in-depth 
studies are required, especially those that correlate the data of rheological studies with the 
results of detailed histological/ biomolecular analyses from the proximal aorta in BAV 
patients. 
In summary, those detailed rheological data provide a unique hemodynamic insight into the 
different clinically observed phenotypes of BAV disease. This pathogenetic background 
should be considered when advocating treatment guidelines for BAV-associated aortopathy. 
2.3 Clustering of patients with BAV aortopathy 
Some efforts have been made to cluster BAV patients according to the anatomical pattern of 
proximal aortic dilatation and to propose “individualized” degrees of aortic replacement for 
these subgroups (Fazel et al., 2008). Hierarchic cluster analysis was proposed by Fazel et al. 
to stratify BAV patients into four distinct patterns of proximal aortic involvement.  
Based on four identified dilatation patterns of the proximal aorta, Itoh et al. (2010) argue that 
a custom-tailored approach to aortic resection is reasonable in patients with BAV and 
should involve the aortic arch in the majority of cases (i.e., in 73% BAV patients undergoing 
surgery) (Itoh et al., 2010). All these surgical considerations are limited by the theoretical 
assumption that all patients with BAV have an underlying connective tissue disorder and 
that aneurismal aortic dilation is not a consequence of the co-existent hemodynamic 
abnormalities. 
There are some major limitations of the study by Fazel et al. (2008), which should be stressed 
when considering such aggressive treatment guidelines for the dilated proximal aorta in the 
setting of a BAV. As discussed in the previous subparagraphs, there is a growing amount of 
evidence supporting the notion that hemodynamic factors are involved in the genesis of 
aortopathy in patients with BAV disease. Therefore, BAV morphology (i.e., different aortic 
valve cusps fusion patterns) and BAV function (i.e., BAV stenosis versus BAV insufficiency) 
should undoubtedly be considered when trying to better discriminate between specific 
subgroups of BAV disease (Della Corte & Cotrufo, 2008). 
Interestingly, Fazel et al. (2008) found the highest prevalence of right coronary and non-
coronary cusp fusion and the highest mean grade of aortic valve insufficiency in the cluster 
of BAV patients with dilatation of the tubular ascending aorta and aortic arch. These 
findings correlate appropriately with the data from the rheological and echocardiographic 
studies by Hope et al., (2010), and Schaefer et al., (2008). Moreover, the retrospective study 
by Fazel et al., (2008) included only a selected (i.e., non-consecutive) cohort of BAV patients, 
for whom thoracic aortic imaging data were available for analysis. 
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Fazel et al., (2008) acknowledged in the discussion of their manuscript that there are no 
follow-up data to support the hypothesis that such an aggressive aortic replacement strategy 
results in decreased postoperative morbidity and mortality over the long term. The 
progression rate of aortic arch aneurysms over years after surgery is currently unknown and 
the 1.9 mm/year growth rate that Fazel et al. (2008) cited refers to the mid-ascending aortic 
tract. 
Moreover, the aforementioned study lacks an accurate comparison of the study population 
with a matched TAV group, as already stressed in the invited commentary by Della Corte & 
Cotrufo (2008). Therefore, it is unclear whether the observed proximal aortic dilation patterns 
are unique to the BAV setting. 
In summary, the presented novel treatment recommendations for the identified BAV 
clusters may not be drawn from purely observational studies, which include only a limited 
number of selective BAV patients and do not respect the hemodynamic background of 
different BAV phenotypes. 
3. Conclusion 
The clinically observed linkage between specific BAV morphology and the associated lesions 
of the proximal aorta has recently led to several phenotypic classifications which incorporate 
both aortic valve and proximal aortic anatomy. These novel BAV phenotypes and the 
fundamental research contributions have been addressed in detail in this chapter. 
The predominant anatomical-clinical BAV phenotype of BAV stenosis with an asymmetric 
mid-ascending aortic dilatation may include those patients in whom the hemodynamic 
factors play the determinant role. The root dilatation phenotype may be subtended by a less 
flow-dependent mechanism of aortic wall failure and may be a purely genetic form of BAV 
disease. This is clearly a completely different disease from BAV stenosis and asymmetric 
mid-ascending aortic dilatation. 
The evidence suggests that the proximal aortic dilatation associated with BAV stenosis 
versus that with BAV insufficiency should be considered as different diseases that may be 
amenable to specific therapeutic approaches. According to discussed in this chapter, it 
seems not justified to extend the surgical procedure to the sinuses of Valsalva in BAV 
patients with aortic valve stenosis and asymmetric mid-ascending aortic dilatation. In 
contrast, a relatively small proportion of young male BAV patients with the root dilatation 
phenotype should probably be treated more radically. 
There is emerging evidence from the recent literature that different cusp fusion patterns in 
BAV disease are associated with specific lesions of the proximal aorta. The presence of more 
severe aortic histopathological changes at a younger age, and a significantly larger aortic 
root diameter in BAV patients with fusion of the left coronary and right coronary cusps may 
be predictive of a more accelerated and “malignant” BAV phenotype. 
It has been convincingly demonstrated that fusion of the left coronary and right coronary 
cusps generates a right-anterior eccentric flow jet, which may hemodynamically explain the 
resulting asymmetric dilatation of the mid-ascending tubular aorta. Fusion of the right 
coronary and non-coronary cusps, which produces a left-posteriorly directed eccentric flow 
jet, might explain the increased aortic arch dimensions in this subgroup of BAV patients. 
However, the paucity of data on the “root dilatation phenotype” precludes any reasonable 
hemodynamic explanation for the larger aortic root dimensions in BAV patients with fusion 
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of the left coronary and right coronary cusps. The aortic root (i.e., sinuses of Valsalva) has 
not been systematically addressed in BAV patients and, accordingly, there are no specific 
data on aortic root morphology in BAV patients with the “root dilatation phenotype”. 
Additional in-depth studies are required, especially those that correlate the data of 
rheological studies with the results of detailed histological/ biomolecular analyses from the 
proximal aorta in BAV patients. 
The pathogenetic background of different BAV phenotypes should be considered when 
advocating treatment guidelines for BAV-associated aortopathy. Data from recent studies 
requires a reevaluation of the overwhelming support of the genetic nature of BAV 
aortopathy, and they oblige us to acknowledge that hemodynamic factors are significantly 
involved in the development of this disease process. Given the described heterogeneity of 
BAV disease, additional studies are under way to more precisely describe which hypothesis 
is the “correct” one for explaining the apparently different phenotypes of BAV disease. 
From a clinical standpoint, there is an urgent need for diagnostic tools to reliably distinguish 
the more from the less “malignant” phenotypes of BAV disease. The combination of protein 
assays (i.e., metalloproteinase 2 plasma levels) and magnetic resonance imaging tests (i.e., 
quantitative measurement of the angle of the misdirected blood flow) has been most 
recently proposed as a future diagnostic tool for clinical risk stratification of different BAV 
phenotypes (den Reijer et al., 2010). Prospective multicenter studies will be needed to prove 
the predictive value of this novel concept. The identification of a BAV phenotype 
representing the more “malignant” form of BAV disease, which would be amenable to the 
more aggressive surgical strategy, still requires special future research efforts. 
In conclusion, in the face of most recent in vitro and in vivo findings on BAV disease, we 
found it necessary to address the issue of phenotypes in BAV disease. We feel that a critical 
review of this clinical problem is crucial, because the different BAV phenotypes may be 
caused by unique pathogenetic mechanisms and may be amenable to different therapeutic 
approaches. Such observations are not simply theoretical in nature: they significantly affect 
our surgical approach to the proximal aorta in patients with this common clinical entity of 
BAV disease. 
4. References 
Arrington, C.; Sower, T.; Chuckwuk, N.; Stevens, J.; Leppert, M.; Yetman, A. & Bowles, N. 
(2008). Absence of TGFBR1 and TGFBR2 mutations in patients with bicuspid aortic 
valve and aortic dilatation. American Journal of Cardiology, Vol. 102, No. 5, 
(September 2008), pp. 629-631, ISSN 0002-9149 
Bauer, M.; Gliech, V.; Siniawski, H. & Hetzer, R. (2006). Configuration of the ascending aorta 
in patients with bicuspid and tricuspid aortic valve disease undergoing aortic valve 
replacement with or without reduction aortoplasty. Journal of Heart Valve Disease, 
Vol. 15, No. 5, (September 2006), pp. 594-600, ISSN 0966-8519 
Biner, S.; Rafique, A.; Ray, I.; Cuk, O.; Siegel, R. & Tolstrup, K. (2009). Aortopathy is 
prevalent in relatives of bicuspid aortic valve patients. Journal of the American 
College of Cardiology, Vol. 53, No. 24, (June 2009), pp. 2288-2295, ISSN 0735-1097 
Conti, C.; Della Corte, A.; Votta, E.; Del Viscovo, L.; Bancone, C.; De Santo, L. & Redaelli, A. 
(2010). Biomechanical implications of the congenital bicuspid aortic valve: a finite 
www.intechopen.com
 
Aortic Valve 
 
328 
element study of aortic root function from in vivo data. Journal of Thoracic and 
Cardiovascular Surgery, Vol. 140, No. 4, (October 2010), pp. 890-896, ISSN 0022-5223 
Cotrufo, M.; Della Corte, A. (2009). The association of bicuspid aortic valve disease with 
asymmetric dilatation of the tubular ascending aorta: identification of a definite 
syndrome. Journal of Cardiovascular Medicine, Vol. 10, No. 4, (April 2009), pp. 291-
297, ISSN 1558-2027 
Cotrufo, M.; De Santo, L.; Esposito, S.; Renzulli, A.; Della Corte, A.; De Feo, M.; Marra, C. & 
Agozzino, L. (2001). Asymmetric medial degeneration of the intrapericardial aorta 
in aortic valve disease. International Journal of Cardiology, Vol.81, No.1, (November 
2001), pp. 37-41, ISSN 0167-5273 
Cotrufo, M.; Della Corte, A.; De Santo, L.; Quarto, C.; De Feo, M.; Romano, G.; Amarelli, C.; 
Scardone, M.; Di Meglio, F.; Guerra, G.; Scarano, M.; Vitale, S.; Castaldo, C. & 
Montagnani, S. (2005). Different patterns of extracellular matrix protein expression 
in the convexity and the concavity of the dilated aorta with bicuspid aortic valve: 
preliminary results. Journal of Thoracic and Cardiovascular Surgery, Vol. 130, No. 2, 
(August 2005), pp. 504-511, ISSN 0022-5223 
Davies, R.; Kaple, R.; Mandapati, D.; Gallo, A.; Botta, D.; Elefteriades, J. & Coady, M. (2007). 
Natural history of ascending aortic aneurysms in the setting of an unreplaced 
bicuspid aortic valve. Annals of Thoracic Surgery, Vol. 83, No. 4, (April 2007), pp. 
1338-1344, ISSN 0003-4975 
Della Corte, A.; De Santo, L.; Montagnani, S.; Quarto, C.; Romano, G.; Amarelli, C.; 
Scardone, M.; De Feo, M.; Cotrufo, M. & Caianiello, G. (2006). Spatial patterns of 
matrix protein expression in dilated ascending aorta with aortic regurgitation: 
congenital bicuspid valve versus Marfan’s syndrome. Journal of Heart Valve Disease, 
Vol. 15, No. 1, (January 2006), pp. 20-27, ISSN 0966-8519 
Della Corte, A.; Bancone, C.; Quarto, C.; Dialetto, G.; Covino, F.; Scardone, M.; Caianiello, G. 
& Cotrufo, M. (2007). Predictors of ascending aortic dilatation with bicuspid aortic 
valve: a wide spectrum of disease expression. European Journal of Cardiothoracic 
Surgery, Vol. 31, No. 3, (March 2007), pp. 397-404, ISSN 1010-7940 
Della Corte, A.; Quarto, C.; Bancone, C.; Castaldo, C.; Di Meglio, F.; Nurzynska, D.; De 
Santo, L.; De Feo, M.; Scardone, M.; Montagnani, S. & Cotrufo, M. (2008). 
Spatiotemporal patterns of smooth muscle sell changes in ascending aortic 
dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix 
signalling. Journal of Thoracic and Cardiovascular Surgery, Vol. 135, No. 1, (January 
2008), pp. 8-18, ISSN 0022-5223 
Della Corte, A. & Cotrufo, M. (2008). Bicuspid aortopathy or bicuspid aortopathies? The risk 
of generalizing. Journal of Thoracic and Cardiovascular Surgery, Vol. 136, No. 6, 
(December 2008) pp. 1604, ISSN 0022-5223 
den Reijer, P.; Sallee 3rd, D.; van der Velden, P.; Zaaijer, E.; Parks, W.; Ramamurthy, S.; 
Robbie, T.; Donati, G.; Lamphier, C.; Beekman, R. & Brummer, M. (2010). 
Hemodynamic predictors of aortic dilatation in bicuspid aortic valve by velocity-
encoded cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic 
Resonance, Vol. 12, No. 1, (January 2010), pp. 4-17, ISSN 1097-6647. 
Fazel, S.; Mallidi, H.; Lee, R.; Sheehan, M.; Liang, D.; Fleischmann, D.; Herfkens, R.; Mitchell, 
R. & Miller, DC. (2008). The aortopathy of bicuspid aortic valve disease has 
www.intechopen.com
 
Novel Phenotypes in Bicuspid Aortic Valve Disease 
 
329 
distinctive patterns and usually involves the transverse aortic arch. Journal of 
Thoracic and Cardiovascular Surgery, Vol. 135, No. 4, (April 2008), pp. 901-907, ISSN 
0022-5223 
Girdauskas, E.; Schulz, S.; Borger, M.; Mierzwa, M. & Kuntze, T (2011). Transforming 
growth factor-beta receptor type II mutation in a patient with bicuspid aortic valve 
disease and intraoperative aortic dissection. Annals of Thoracic Surgery, (in press), 
doi:10.1016/j.athoracsur.2010.12.060 
Girdauskas, E.; Borger, M.; Secknus, M.; Girdauskas, G. & Kuntze, T. (2011). Is aortopathy in 
bicuspid aortic valve disease a congenital defect or a result of abnormal 
hemodynamics? A critical reappraisal of a one-sided argument. European Journal of 
Cardiothoracic Surgery, (February 2011), doi:10.1016/j.ejcts.2011.01.001 
Guntheroth, W. (2008). A critical review of the ACC/AHA practice guidelines on bicuspid 
aortic valve with dilated ascending aorta. American Journal of Cardiology, Vol. 102, 
No. 1, (July 2008), pp. 107-110. ISSN 0002-9149 
Itoh, A.; Fischbein, M.; Arata, K. & Miller, DC. (2010). „Peninsula-style“ transverse aortic 
arch replacement in patients with bicuspid aortic valves. Annals of Thoracic Surgery, 
Vol. 90, No. 4, (October 2010), pp. 1369-1371, ISSN 0003-4975 
Holmes, K.; Lehmann, C.; Dalal, D.; Nasir, K.; Dietz, H.; Ravekes, W.; Thompson, W. & 
Spevak, P. (2007). Progressive dilation of the ascending aorta in children with 
isolated bicuspid aortic valve. American Journal of Cardiology, Vol. 99, No. 7, (April 
2007), pp. 978-983, ISSN 0002-9149 
 Hope, M.; Hope, T.; Meadows, A.; Ordovas, K.; Urbania, T.; Alley, M. & Higgins, C. 
(2010). Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic 
systolic flow pattern. Radiology, Vol.255, No.1, (April 2010), pp. 53-61, ISSN 0033-
8419 
Hope, M.; Hope, T.; Meadows, A.; Ordovas, K.; Urbania, T.; Alley, M. & Higgins, C. (2010). 
Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic 
flow patterns. Radiology, Vol. 255, No. 1, (April 2010), pp. 53-61, ISSN 0033-8419 
Lehoux, S.; Tronc, F. & Tedgui, A. (2002). Mechanisms of blood flow-induced vascular 
enlargement. Biorheology, Vol. 39, No. 3-4, (January 2002), pp. 319-324, ISSN 0006-
355X 
Loscalzo, M.; Goh, D.; Loeys, B.; Kent, K.; Spevak, P. & Dietz, H. (2007). Familial thoracic 
aortic dilation and bicommissural aortic valve: a prospective analysis of natural 
history and inheritance. American Journal of Medical Genetics Part A, Vol. 143A, No. 
17, (September 2007), pp. 1960-1967, ISSN 1552-4825 
Nistri, S.; Sorbo, M.; Marin, M.; Palisi, M.; Scognamiglio, R. & Thiene, G. (1999). Aortic root 
dilatation in young men with normally functioning bicuspid aortic valves. Heart, 
Vol. 82, No. 1, (July 1999), pp. 19-22, ISSN 1355-6037 
Robicsek, F.; Thubrikar, M.; Cook, J. & Fowler, B. (2004). The congenitally bicuspid aortic 
valve: how does it function? Why does it fail? Annals of Thoracic Surgery, Vol. 77, 
No. 1, (January 2004), pp. 177-185, ISSN 0003-4975 
Russo, C.; Cannata, A.; Lanfranconi, M.; Vitali, E.; Garatti, A. & Bonacina, E. (2007). Is aortic 
wall degeneration related to bicuspid aortic valve anatomy in patients with 
valvular disease? Journal of Thoracic and Cardiovascular Surgery, Vol. 136, No. 4, 
(October 2008), pp. 937-942, ISSN 0022-5223 
www.intechopen.com
 
Aortic Valve 
 
330 
Schaefer, B.; Lewin, M.; Stout, K.; Byers, P. & Otto, C. (2007). Usefulness of bicuspid aortic 
valve phenotype to predict elastic properties of the ascending aorta. American 
Journal of Cardiology, Vol. 99, No. 5, March 2007), pp. 686-690, ISSN 0002-9149 
Schaefer, B.; Lewin, M.; Stout, K.; Gill, E.; Prueitt, A.; Byers, P. & Otto, C (2008). The bicuspid 
aortic valve: an integrated phenotypic classification of leaflet morphology and 
aortic root shape. Heart, Vol. 94, No. 12, (December 2008), pp. 1634-1638, ISSN 1355-
6037 
Sievers, H. & Schmidtke C (2007). A classification system for the bicuspid aortic valve from 
304 surgical specimens. Journal of Thoracic and Cardiovascular Surgery, Vol. 133, No. 
5, (May 2007), pp. 1226-1233, ISSN 0022-5223 
Williams, DS. (2006). Bicuspid aortic valve. Journal of Insurance Medicine, Vol. 38, No. 1, pp. 
72-74, ISSN 0743-6661 
www.intechopen.com
Aortic Valve
Edited by Prof. Chen Ying-Fu
ISBN 978-953-307-561-7
Hard cover, 350 pages
Publisher InTech
Published online 09, December, 2011
Published in print edition December, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Much has evolved in the field of aortic valve disease because of the increase in knowledge in the last decade,
especially in the area of its management. This book "Aortic Valve" is comprised of 18 chapters covering basic
science, general consideration of aortic valve disease, infective endocarditis, aortic sclerosis and aortic
stenosis, bioprosthetic valve, transcatheter aortic valve implantation and a special section on congenital
anomalies of the aortic valve. We hope this book will be particularly useful to cardiologists and cardiovascular
surgeons and trainees. We also believe that this book will be a valuable resource for radiologists, pathologists,
cardiovascular anesthesiologists, and other healthcare professionals who have a special interest in treating
patients with aortic valve disease. We are certain that information in this book will help to provide virtually most
new areas of aortic valve disease that will be employed in the current era.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Evaldas Girdauskas, Michael A. Borger and Thomas Kuntze (2011). Novel Phenotypes in Bicuspid Aortic Valve
Disease, Aortic Valve, Prof. Chen Ying-Fu (Ed.), ISBN: 978-953-307-561-7, InTech, Available from:
http://www.intechopen.com/books/aortic-valve/novel-phenotypes-in-bicuspid-aortic-valve-disease
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
